Millennium Management’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.89M | Buy |
3,539,860
+1,054,584
| +42% | +$1.16M | ﹤0.01% | 2241 |
|
2025
Q1 | $2.44M | Sell |
2,485,276
-495,630
| -17% | -$486K | ﹤0.01% | 2468 |
|
2024
Q4 | $4.65M | Buy |
2,980,906
+1,073,928
| +56% | +$1.68M | ﹤0.01% | 2038 |
|
2024
Q3 | $7M | Buy |
1,906,978
+570,070
| +43% | +$2.09M | ﹤0.01% | 1767 |
|
2024
Q2 | $4.43M | Buy |
1,336,908
+753,899
| +129% | +$2.5M | ﹤0.01% | 2001 |
|
2024
Q1 | $2.48M | Buy |
583,009
+569,737
| +4,293% | +$2.43M | ﹤0.01% | 2447 |
|
2023
Q4 | $23.9K | Buy |
+13,272
| New | +$23.9K | ﹤0.01% | 3885 |
|
2023
Q3 | – | Sell |
-30,878
| Closed | -$79K | – | 4492 |
|
2023
Q2 | $79K | Buy |
+30,878
| New | +$79K | ﹤0.01% | 3899 |
|
2023
Q1 | – | Sell |
-31,334
| Closed | -$42K | – | 4876 |
|
2022
Q4 | $42K | Sell |
31,334
-58,504
| -65% | -$78.4K | ﹤0.01% | 4490 |
|
2022
Q3 | $177K | Sell |
89,838
-52,977
| -37% | -$104K | ﹤0.01% | 4501 |
|
2022
Q2 | $340K | Buy |
+142,815
| New | +$340K | ﹤0.01% | 4151 |
|
2022
Q1 | – | Sell |
-10,253
| Closed | -$112K | – | 5547 |
|
2021
Q4 | $112K | Buy |
+10,253
| New | +$112K | ﹤0.01% | 4845 |
|